RYR2 and catecholaminergic polymorphic ventricular tachycardia: In this study, we evaluate the efficacy of carvedilol and flecainide in abolishing Ca2+ abnormalities in CPVT patient-specific hiPSC-derived CMs carrying different mutations in RYR2.